Figures & data
Scheme 1 Synthesis of 7-hydroxy-4-formyl coumarin (3) and 7-methoxy-4-formyl coumarin (4). Reagents and conditions: (a) 7-hydroxy-4-methyl coumarin (1), hot xylene, selenium dioxide, reflux for 12 h, 135–140 °C, filtration, yield = 22%; (b) 7-methoxy-4-methyl coumarin (2), hot xylene, selenium dioxide, reflux for 12 h, 135–140 °C, filtration, yield = 31%.
![Scheme 1 Synthesis of 7-hydroxy-4-formyl coumarin (3) and 7-methoxy-4-formyl coumarin (4). Reagents and conditions: (a) 7-hydroxy-4-methyl coumarin (1), hot xylene, selenium dioxide, reflux for 12 h, 135–140 °C, filtration, yield = 22%; (b) 7-methoxy-4-methyl coumarin (2), hot xylene, selenium dioxide, reflux for 12 h, 135–140 °C, filtration, yield = 31%.](/cms/asset/5affbd10-cf53-44fc-835f-7bbb9302ff5b/dddt_a_12182367_f0001_b.jpg)
Scheme 2 Synthesis of compound (5) (thiosemicarbazide Schiff base derivative). Reagents and conditions: 7-hydroxy-4-formyl coumarin (3), thiosemicarbazide, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 67%.
![Scheme 2 Synthesis of compound (5) (thiosemicarbazide Schiff base derivative). Reagents and conditions: 7-hydroxy-4-formyl coumarin (3), thiosemicarbazide, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 67%.](/cms/asset/b198cb77-0e44-4768-afef-7a7c42e1b404/dddt_a_12182367_f0002_b.jpg)
Scheme 3 Synthesis of compounds (6), (7), and (8). Reagents and conditions: (a) 7-methoxy-4-formyl coumarin (4), 4-aminobenzoic acid, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 87%; (b) 7-methoxy-4-formyl coumarin (4), 5-amino-1,3,4-thiadiazole-2-thiol, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 56%; (c) 7-methoxy-4-formyl coumarin (4), 4-aminoacetophenone, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 71%.
![Scheme 3 Synthesis of compounds (6), (7), and (8). Reagents and conditions: (a) 7-methoxy-4-formyl coumarin (4), 4-aminobenzoic acid, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 87%; (b) 7-methoxy-4-formyl coumarin (4), 5-amino-1,3,4-thiadiazole-2-thiol, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 56%; (c) 7-methoxy-4-formyl coumarin (4), 4-aminoacetophenone, ethanol, reflux for 7 h, 75–80 °C, filtration and recrystallization, yield = 71%.](/cms/asset/f719aba9-aec3-411b-93de-2070ca1ec1a2/dddt_a_12182367_f0003_b.jpg)
![](/cms/asset/a919e328-c4e6-4ff8-8dba-7798ec64274c/dddt_a_12182367_uf0001_c.jpg)
![](/cms/asset/a99e209c-a555-436d-bbad-aed25aa5b263/dddt_a_12182367_uf0002_c.jpg)
![](/cms/asset/156183ba-e40d-4ce6-9687-feb6ca76fddf/dddt_a_12182367_uf0003_c.jpg)
![](/cms/asset/2da675c8-54f0-49d1-b73c-5ac7b8a0e0bf/dddt_a_12182367_uf0004_c.jpg)
Figure 1 Chemical structures of the synthesized coumarin Schiff base derivatives. Compound 3, 7-hydroxy-4-formyl coumain; compound 4, 7-methoxy-4-formyl coumarin; compound 5, thiosemicarbazide derivative of 7-hydroxy-4-formyl coumarin; compound 6, p-aminoacetophenone derivative of 7-methoxy-4-formyl coumarin; compound 7, 5-amino-1,3,4-thiadiazole-2-thiol derivative of 7-methoxy-4-formyl coumarin; compound 8, p-aminobenzoic acid derivative of 7-methoxy-4-formyl coumarin.
![Figure 1 Chemical structures of the synthesized coumarin Schiff base derivatives. Compound 3, 7-hydroxy-4-formyl coumain; compound 4, 7-methoxy-4-formyl coumarin; compound 5, thiosemicarbazide derivative of 7-hydroxy-4-formyl coumarin; compound 6, p-aminoacetophenone derivative of 7-methoxy-4-formyl coumarin; compound 7, 5-amino-1,3,4-thiadiazole-2-thiol derivative of 7-methoxy-4-formyl coumarin; compound 8, p-aminobenzoic acid derivative of 7-methoxy-4-formyl coumarin.](/cms/asset/cd3202e5-6c0c-47aa-a788-0e6d8937ff9a/dddt_a_12182367_f0004_b.jpg)
Table 1 Calculated Binding Free Energy, Ki, Run Number of the Highest Δgbinding, LogP, H-Bond Donor, H-Bond Acceptor, and Molar Mass of the Designed Molecules and Ibuprofen
Figure 2 Binding interactions between ibuprofen and the COX-2 binding site. (A) Conformation of ibuprofen in the receptor-binding pocket. (B) The intermolecular binding interactions between ibuprofen and COX-2 presented by Ligplot plus program. The hydrophobic interactions between the ligand and COX-2, red lines; H-bonds, green lines; and protein residues involved in hydrophobic contacts, red spikes.
![Figure 2 Binding interactions between ibuprofen and the COX-2 binding site. (A) Conformation of ibuprofen in the receptor-binding pocket. (B) The intermolecular binding interactions between ibuprofen and COX-2 presented by Ligplot plus program. The hydrophobic interactions between the ligand and COX-2, red lines; H-bonds, green lines; and protein residues involved in hydrophobic contacts, red spikes.](/cms/asset/194f3421-668a-4c84-bea9-7942a0a00e04/dddt_a_12182367_f0005_c.jpg)
Figure 3 Binding interactions between compound 5 and the COX-2 binding site. (A) Conformation of the ligand in the receptor active site. (B) Intermolecular binding interaction displayed by Ligplot plus program. Hydrophobic bonds between compound 5 and COX-2, red dashed lines; H-bonds, green dashed lines; and protein residues involved in hydrophobic interactions, red arcs.
![Figure 3 Binding interactions between compound 5 and the COX-2 binding site. (A) Conformation of the ligand in the receptor active site. (B) Intermolecular binding interaction displayed by Ligplot plus program. Hydrophobic bonds between compound 5 and COX-2, red dashed lines; H-bonds, green dashed lines; and protein residues involved in hydrophobic interactions, red arcs.](/cms/asset/64959e18-8e45-4f62-9ee9-939298af0bcd/dddt_a_12182367_f0006_c.jpg)
Figure 4 Binding interactions between compound 7 and COX-2 isoform. (A) Conformation of compound 7 in the receptor active pocket. (B) Demonstration of the binding interactions between compound 7 and COX-2. H-bonds, green dashed lines; receptor residues involved in hydrophobic contacts, red arcs; and ligand-protein hydrophobic interactions, red dotted lines.
![Figure 4 Binding interactions between compound 7 and COX-2 isoform. (A) Conformation of compound 7 in the receptor active pocket. (B) Demonstration of the binding interactions between compound 7 and COX-2. H-bonds, green dashed lines; receptor residues involved in hydrophobic contacts, red arcs; and ligand-protein hydrophobic interactions, red dotted lines.](/cms/asset/58e50b31-d511-4cdc-b4ad-563719315a20/dddt_a_12182367_f0007_c.jpg)
Figure 6 Protein denaturation assay of the synthesized ligands (Schiff base derivatives) and ibuprofen based on the compound concentration. Values represent means of triplicate readings. Ibu, Ibuprofen; 5, compound 5; 6, compound 6; 7, compound 7; 8, compound 8.
![Figure 6 Protein denaturation assay of the synthesized ligands (Schiff base derivatives) and ibuprofen based on the compound concentration. Values represent means of triplicate readings. Ibu, Ibuprofen; 5, compound 5; 6, compound 6; 7, compound 7; 8, compound 8.](/cms/asset/7851664c-5cff-451b-908d-3e3a3e02ff40/dddt_a_12182367_f0009_c.jpg)
Table 2 Pearson’s Correlation, Coefficient of Determination, and the Level of Significance for the Schiff Base Derivative Ligands and Ibuprofen